Active Biotech AB | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
376,195.00
328,455.00
103,617.00
77,677.00
25,152.00
25,552
Total Accounts Receivable
6,840.00
9,374.00
13,925.00
4,902.00
2,866.00
2,038
Other Current Assets
3,737.00
3,054.00
2,095.00
2,224.00
274,081.00
273,574
Total Current Assets
386,772.00
340,883.00
119,637.00
84,803.00
302,099.00
301,164
Net Property, Plant & Equipment
381,034.00
381,636.00
329,802.00
328,071.00
1,713.00
1,266
Long-Term Note Receivable
1.00
1.00
1.00
1.00
1.00
1
Total Assets
767,807.00
722,520.00
449,440.00
412,875.00
303,813.00
302,431
ST Debt & Current Portion LT Debt
6,899.00
6,898.00
6,490.00
9,320.00
210,115.00
Accounts Payable
34,353.00
24,432.00
6,625.00
3,898.00
3,629.00
Income Tax Payable
34.00
1,215.00
1,118.00
796.00
34.00
Other Current Liabilities
97,064.00
62,030.00
38,332.00
9,348.00
12,061.00
Total Current Liabilities
138,350.00
94,575.00
52,565.00
23,362.00
225,839.00
Long-Term Debt
224,046.00
222,639.00
216,272.00
206,958.00
297.00
Total Liabilities
362,396.00
317,214.00
268,837.00
230,320.00
226,136.00
Common Equity (Total)
405,411.00
405,306.00
180,603.00
182,555.00
77,677.00
Total Shareholders' Equity
405,411.00
405,306.00
180,603.00
182,555.00
77,677.00
Total Equity
405,411.00
405,306.00
180,603.00
182,555.00
77,677.00
Liabilities & Shareholders' Equity
767,807.00
722,520.00
449,440.00
412,875.00
303,813.00

About Active Biotech AB

View Profile
Address
Scheelevägen 22
Lund SN 223 63
Sweden
Employees -
Website http://www.activebiotech.com
Updated 07/08/2019
Active Biotech AB develops pharmaceutical preparations. It develops pharmaceutical products within medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease and various forms of cancer. The company's project portfolio comprises small, orally active immunomodulatory molecules as well as antibody-based immunotherapy.